THE turning point was the Brexit referendum. Before voting to leave the EU in June 2016, medicine shortages were not something the UK often had to worry about.
But once the votes had been counted, the UK Government realised that it may have an issue on its hands. As well as urging pharmacists to stockpile a six-week supply of key medicines ahead of the transition period ending, Whitehall also started to keep a close eye on drug shortages and supply.
“A lot of the measures for medicine shortage were brought in as the Government in London tried to prepare for Brexit and anticipated, probably correctly, that it would have a really big effect on medicine supplies,” Mark Dayan, the Brexit Programme Lead at the Nuffield Trust told the Sunday National.
READ MORE: Bed blocking and Brexit: How leaving the EU has worsened the NHS crisis
And issues with medicine supply in the UK didn’t start with the end of the transition period. They began almost as soon as the 2016 referendum results came in. And there is one measure which predates Brexit which highlights this: UK Government-approved price concessions for imported medicine.
These concessions have an immediate knock-on impact on an already over-stretched NHS budget. The more the health service pays for medicine, the less it has to spare elsewhere.
Before the referendum in June 2016, the Department of Health and Social Care had never needed to issue more than two dozen at a time.
Since mid-2016, the number of concessions being issued has climbed higher and higher. After the impact of Liz Truss’s disastrous mini-Budget – which saw the pound sterling hit record lows against the US dollar – the UK was forced to issue around eight times more concessions than it ever had before the Brexit vote.
These price concessions are “really an indicator of shortage or pressure on supplies”, Dayan explains. Worryingly, the low numbers being approved before the 2016 vote have not been seen again since.
The UK’s decision to exit the EU impacted immediately on medicine supply and cost concessions through the devaluation of the sterling. Exit polls predicting a Leave victory saw the pound slump to a three-decade low from which it has never recovered.
The NHS has to spend more of its pounds to get the same amount of medicine as it had before “because of perceptions about what Brexit would mean,” Dayan says.
He adds that while medicine shortages are a global issue at the moment, “there is evidence that aspects of this in the UK have been exacerbated by Brexit”.
A weakened pound is not the only way in which leaving the EU looks to have impacted on medicine supplies and prices in the UK. “Bureaucracy and barriers at the border” may also have added to prices, leading to more concessions having to be made.
“Particularly for generic medicines which are not expensive [and not] high-end products where extra transport costs can be soaked up,” Dayan says. “They’re price-competitive, bulk, commodity products. A change in transport costs could have an effect.
“In many cases they would have been supplied on a whole-Europe basis before [Brexit]. Some will be shipped straight to the UK, but many will be shipped to Rotterdam or Hamburg etcetera.”
And looking to the future, the UK may find itself outside of key measures to combat medicine shortages being looked at by the EU.
On Thursday, the Financial Times reported that the European Commission was looking to tackle problems it is facing through stockpiling drugs and obliging manufacturers to guarantee supplies.
Dayan warned that the UK may need to look at taking such policy moves on, as it will “not be part of EU anti-shortage measures”.
“If the EU does stockpile a lot of these common medicines for example for infectious diseases, the UK will be out of that,” he says. “It may have to consider stockpiling for itself again.”
A surge in Covid, cold, and flu cases – especially in children – across the northern hemisphere has left some basic medicines in short supply. But soon the issue could be elsewhere.
“Crises tend to jump from one [drug] to the other,” Dayan says.
“At the moment the UK, and actually many countries, are in a really difficult situation with medicine shortages and it’s gotten much, much worse in recent years.”
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel